349 related articles for article (PubMed ID: 25841699)
41. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
42. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
Torchilin VP
Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
[TBL] [Abstract][Full Text] [Related]
43. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier.
Yamada Y; Harashima H
Mitochondrion; 2013 Sep; 13(5):526-32. PubMed ID: 23000575
[TBL] [Abstract][Full Text] [Related]
44. Surface modification and local orientations of surface molecules in nanotherapeutics.
Amin ML; Joo JY; Yi DK; An SS
J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
[TBL] [Abstract][Full Text] [Related]
45. Restoration of mitochondria function as a target for cancer therapy.
Bhat TA; Kumar S; Chaudhary AK; Yadav N; Chandra D
Drug Discov Today; 2015 May; 20(5):635-43. PubMed ID: 25766095
[TBL] [Abstract][Full Text] [Related]
46. The 17th International Symposium on Recent Advances in Drug Delivery, June 14-17, 2015, Salt Lake City, UT, USA. Preface.
Grainger DW; Bae YH
J Control Release; 2015 Dec; 220(Pt B):569-70. PubMed ID: 26686491
[No Abstract] [Full Text] [Related]
47. Approaches for targeting mitochondria in cancer therapy.
D'Souza GG; Wagle MA; Saxena V; Shah A
Biochim Biophys Acta; 2011 Jun; 1807(6):689-96. PubMed ID: 20732297
[TBL] [Abstract][Full Text] [Related]
48. The involvement of the mitochondrial membrane in drug delivery.
Huang Y; Ji W; Zhang J; Huang Z; Ding A; Bai H; Peng B; Huang K; Du W; Zhao T; Li L
Acta Biomater; 2024 Mar; 176():28-50. PubMed ID: 38280553
[TBL] [Abstract][Full Text] [Related]
49. Assessing the Delivery of Molecules to the Mitochondrial Matrix Using Click Chemistry.
Hoogewijs K; James AM; Smith RA; Gait MJ; Murphy MP; Lightowlers RN
Chembiochem; 2016 Jul; 17(14):1312-6. PubMed ID: 27124570
[TBL] [Abstract][Full Text] [Related]
50. Current and upcoming mitochondrial targets for cancer therapy.
Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
[TBL] [Abstract][Full Text] [Related]
51. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
Baker JR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
[TBL] [Abstract][Full Text] [Related]
52. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
53. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
[TBL] [Abstract][Full Text] [Related]
54. Shaping mitochondria: The complex posttranslational regulation of the mitochondrial fission protein DRP1.
Santel A; Frank S
IUBMB Life; 2008 Jul; 60(7):448-55. PubMed ID: 18465792
[TBL] [Abstract][Full Text] [Related]
55. Delivery to mitochondria: a narrower approach for broader therapeutics.
Malhi SS; Murthy RS
Expert Opin Drug Deliv; 2012 Aug; 9(8):909-35. PubMed ID: 22663303
[TBL] [Abstract][Full Text] [Related]
56. Mitochondria: a therapeutic target in acute kidney injury.
Ishimoto Y; Inagi R
Nephrol Dial Transplant; 2016 Jul; 31(7):1062-9. PubMed ID: 26333547
[TBL] [Abstract][Full Text] [Related]
57. Mitochondria-targeted drug delivery system for cancer treatment.
Chen ZP; Li M; Zhang LJ; He JY; Wu L; Xiao YY; Duan JA; Cai T; Li WD
J Drug Target; 2016; 24(6):492-502. PubMed ID: 26548930
[TBL] [Abstract][Full Text] [Related]
58. Toward high-content screening of mitochondrial morphology and membrane potential in living cells.
Iannetti EF; Willems PH; Pellegrini M; Beyrath J; Smeitink JA; Blanchet L; Koopman WJ
Int J Biochem Cell Biol; 2015 Jun; 63():66-70. PubMed ID: 25668473
[TBL] [Abstract][Full Text] [Related]
59. Formulation and optimization of mitochondria-targeted polymeric nanoparticles.
Marrache S; Pathak RK; Dhar S
Methods Mol Biol; 2015; 1265():103-12. PubMed ID: 25634270
[TBL] [Abstract][Full Text] [Related]
60. Overview of challenges and opportunities in drug delivery and pharmaceutics.
Panicucci R; Sanchez-Felix M
Ther Deliv; 2015; 6(8):911-4. PubMed ID: 26305510
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
